Stock listing

BBOT Stock Price, News, Filings & Events — Bridgebio Oncology Therapeutics, Inc.

Selected listing: BBOT · NASDAQ · USD · US

This page tracks Bridgebio Oncology Therapeutics, Inc.'s BBOT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BBOT:NASDAQ. BBOT:NASDAQ is the stock-level entry point for investors researching Bridgebio Oncology Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bridgebio Oncology Therapeutics, Inc. is a public company listed under the ticker BBOT, operating in the American market. The company focuses on developing innovative therapies for cancer treatment. As of now, Bridgebio has a market capitalization of approximately $666.5 million.